Blaise Lippa Email & Phone Number
@morphictx.com
3 phones found area 781
LinkedIn matched
Who is Blaise Lippa? Overview
A concise factual answer block for searchers comparing this professional profile.
Blaise Lippa is listed as CXO at Curie.Bio, based in Waltham, Massachusetts, United States. AeroLeads shows a work email signal at morphictx.com, phone signal with area code 781, and a matched LinkedIn profile for Blaise Lippa.
Blaise Lippa previously worked as Chief Scientific Officer at Morphic Therapeutic and Sr. Vice President of Molecular Discovery at Morphic Therapeutic. Blaise Lippa holds Ph.D., Organic Chemistry from Stanford University.
Email format at Curie.Bio
This section adds company-level context without repeating Blaise Lippa's masked contact details.
AeroLeads found 1 current-domain work email signal for Blaise Lippa. Compare company email patterns before reaching out.
About Blaise Lippa
Built startup from founding (2015) to 130 employees with multiple assets, and raised >$800M (equity + partnerships). Completed successful IPO (2019) followed by company acquisition by Lilly for $3.2B (2024). Proven track record advancing molecules to clinical trials, including the approved drug Daurismo/ Glasdegib for leukemia. Experienced in multiple disease areas (oncology, immunology, pain, antibacterials, IBD, fibrosis), and target types (kinase, GPCR, ion channel, PPI, protease). Member of early and late stage clinical development teams (IND -> NDA -> commercialization). Motivated and goal-oriented leader adept at working both in startups and large pharma environments. Proven experience in creating new companies, crisp decision making, introducing innovative technologies, and developing people as scientists and managers.
Listed skills include Drug Discovery, Medicinal Chemistry, Drug Design, Drug Development, and 8 others.
Blaise Lippa's current company
Company context helps verify the profile and gives searchers a useful next step.
Blaise Lippa work experience
A career timeline built from the work history available for this profile.
Chief Scientific Officer
Current- Leading all research and translational sciences at Morphic (56 FTEs)
- Responsible for multiple therapeutic areas (Immunology, Fibrosis, PAH, Oncology), and scientific disciplines (Biology, Translational, Structural Biology, Bioinformatics, Chemoinformatics and Medicinal Chemistry)
Sr. Vice President Of Molecular Discovery
- Leading all Molecular Discovery at Morphic, including Structural Biology, Antibody Discovery, Chemistry, Computational Modeling and Biological Screening
- Responsible for protein expression, purification, crystallization and solving complex structures
- Overseeing antibody discovery efforts, including hybridoma and phage display
Vice President, Chemistry
- Responsible for hiring research team from founding, and initiating multiple integrin projects
- Leadership role for Schrödinger partnership, and other CRO/ CDMOs
Sab Member
Current
Senior Director Of Medicinal Chemistry
- Co-leader of Cubist Medicinal Chemistry Department (26 FTEs)
- Led efforts advancing antibacterial, pain and acute care projects to the clinic with multi-disciplinary project teams
- Won 2011 Cubist Employee of the Year, and Team of the Year (as team leader) awards
- Member of Ceftolozane/ Tazobactam (Zerbaxa®) development core team during advanced clinical trials, NDA submission, and market positioning
Director
- Led a group of 12 chemists directly (4 Ph.D., 8 B.S./M.S.)
- Project team leader for multiple projects in the pain and antibacterial therapeutic areas; capable of leading 3 large projects simultaneously (> 50 internal FTEs)
- Key leader of external collaborations, including Heptares (GPCR structural biology) and Hydra (ion channels)
Senior Principal Scientist
- Lead medicinal chemistry designer in the metabolic disease therapeutic area (2007-2008)
- Advanced projects for diabetes, frailty, and osteoporosis
- Lead medicinal chemistry designer in the antibacterials therapeutic area (2006-2007)
Principal Scientist
- Project team leader of AKT oncology project with > 20 FTEs (chemistry, biology, computational chemistry, PK, toxicology, and pharm. sci.). Conceived the crucial molecular design that led to high kinase selectivity and.
- Conceived and advanced an idea for a novel exploratory project targeting tumor stem cells (Hedgehog pathway/ Smo). Successfully advocated for project launch and led initial team. Compound ultimately FDA approved.
Senior Scientist
- Initiated a global kinase selectivity panel leading to a Pfizer Recognition Award
- Advanced multiple oncology projects in Discovery
Blaise Lippa education
Ph.D., Organic Chemistry
B.S., Chemistry And Cellular Molecular Biology
Education record
Frequently asked questions about Blaise Lippa
Quick answers generated from the profile data available on this page.
What company does Blaise Lippa work for?
Blaise Lippa works for Curie.Bio.
What is Blaise Lippa's role at Curie.Bio?
Blaise Lippa is listed as CXO at Curie.Bio.
What is Blaise Lippa's email address?
AeroLeads has found 1 work email signal at @morphictx.com for Blaise Lippa at Curie.Bio.
What is Blaise Lippa's phone number?
AeroLeads has found 3 phone signal(s) with area code 781 for Blaise Lippa at Curie.Bio.
Where is Blaise Lippa based?
Blaise Lippa is based in Waltham, Massachusetts, United States while working with Curie.Bio.
What companies has Blaise Lippa worked for?
Blaise Lippa has worked for Curie.Bio, Morphic Therapeutic, Proteinqure, Cubist Pharmaceuticals, and Pfizer.
How can I contact Blaise Lippa?
You can use AeroLeads to view verified contact signals for Blaise Lippa at Curie.Bio, including work email, phone, and LinkedIn data when available.
What schools did Blaise Lippa attend?
Blaise Lippa holds Ph.D., Organic Chemistry from Stanford University.
What skills is Blaise Lippa known for?
Blaise Lippa is listed with skills including Drug Discovery, Medicinal Chemistry, Drug Design, Drug Development, Organic Chemistry, Lead Change, Life Sciences, and High Throughput Screening.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial